Form 13G Alector For: 14 May
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Alector Inc (ALEC)
Assess today's live Alector Inc (ALEC) share price, performance and insights using our live NASDAQ: ALEC stock exchange data.
Analyse the historical data and Alector Inc share price performance charts on this page. Our technical summary section provides analysis on Alector share price buy/sell indicators using real-time data (or discuss the Alector (ALEC) stock price today with other investors in the Alector NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ ALEC share price (ISIN: US0144421072) to enhance your trading decisions with our free investment tools and resources.
What Is the Alector Inc Share Price Today?
The Alector share price today is 2.11.
What Is the Stock Symbol for Alector Inc
The stock symbol (or 'ticker') for Alector Inc is "ALEC."
What Stock Exchange Does Alector Inc Trade On?
Alector Inc is listed and trades on the NASDAQ stock exchange.
Is Alector Inc a Good Stock to Buy?
Determining whether Alector Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Alector Inc share price performance charts on this page. Our technical summary section provides analysis on Alector share price buy/sell indicators using real-time data (or discuss the Alector (ALEC) stock price today with other investors in the Alector NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ ALEC share price (ISIN: US0144421072) to enhance your trading decisions with our free investment tools and resources.
What Is the Alector Inc Share Price Today?
The Alector share price today is 2.11.
What Is the Stock Symbol for Alector Inc
The stock symbol (or 'ticker') for Alector Inc is "ALEC."
What Stock Exchange Does Alector Inc Trade On?
Alector Inc is listed and trades on the NASDAQ stock exchange.
Is Alector Inc a Good Stock to Buy?
Determining whether Alector Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.02
2.16
52 wk Range
1.09
3.40
ALEC is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.022.16
52 wk Range
1.093.40
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ALEC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
3.10
Upside
+46.92%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Alector Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form 8K Alector Inc For: 7 May
- Investing.com
- Form 424B5 Alector Inc For: 7 May
- Investing.com
- Form 13G Alector For: 14 May
- Investing.com
- Form 8K Alector Inc For: 7 May
- Investing.com
- Form 424B5 Alector Inc For: 7 May
- Investing.com
- Alector Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell
Analyst Ratings
3 Buy
2 Hold
2 Sell
Ratings:
7 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 3.10
(+46.92% Upside)
Alector Inc Earnings Call Summary for Q2/2025
- Alector beats Q2 2025 forecasts: EPS of -$0.30 vs -$0.47 expected, revenue of $7.9M vs $4.7M anticipated
- Strong cash position of $307.3M expected to last into 2027; stock up 2.1% after hours to $1.46
- Phase III trial of Latozinimab for FTD and Phase II for Alzheimer's progressing; results expected mid-Q4 2025
- 2025 guidance: Collaboration revenue $13-18M, R&D expenses $130-140M; focus on neurodegenerative therapies
- Challenges include regulatory hurdles, market competition, and maintaining financial sustainability
Last Updated: 08/08/2025, 11:36
Read Full TranscriptEarnings
Latest Release
07/05/2026
EPS / Forecast
-0.21 / -0.28
Revenue / Forecast
1.05M / 10.2M
Compare ALEC to Peers and Sector
Metrics to compare | ALEC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipALECPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.9x | −1.5x | −0.5x | |
PEG Ratio | −0.30 | −0.06 | 0.00 | |
Price/Book | 22.6x | 2.7x | 2.6x | |
Price / LTM Sales | 12.7x | 12.0x | 3.1x | |
Upside (Analyst Target) | −5.2% | 113.0% | 55.1% | |
Fair Value Upside | Unlock | 12.8% | 7.2% | Unlock |
Alector, Inc., a clinical stage biotechnology company, develops therapies to counteract the progression of neurodegeneration in the United States. Its pipeline includes Nivisnebart, an investigational human recombinant monoclonal antibody for treating prevalent neurodegenerative diseases; AL137, an anti-amyloid beta antibody paired in preclinical development for the potential treatment of Alzheimer’s disease; and AL050, a GCase enzyme replacement therapy in preclinical development for the potential treatment of Parkinson’s disease and Lewy body dementia in patients having GBA1 gene mutations. The company also develops its preclinical and research pipeline comprising AL064, a tau siRNA for Alzheimer’s disease and other tauopathies; ADP062-ABC, an alpha-synuclein siRNA for Parkinson’s disease; and ADP065-ABC, an NLRP3 siRNA for neurodegenerative conditions. It has a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of progranulin-elevating monoclonal antibodies, including Latozinemab and Nivisnebart. The company was founded in 2013 and is headquartered in South San Francisco, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Alector (NASDAQ: ALEC) Share Price Today?
The Alector stock price today is 2.11 USD.
What Stock Exchange Does Alector (ALEC) Trade On?
Alector is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Alector?
The stock symbol (also called a 'ticker') for Alector is "ALEC."
What Is the Current Alector Market Capitalisation?
As of today, Alector (NASDAQ: ALEC) market cap is 234.26M USD.
What Is Alector's (ALEC) Earnings Per Share (TTM)?
The Alector EPS is currently -1.19 (Trailing Twelve Months).
When Is the Next Alector Earnings Date?
Alector's next earnings report will be released on 30/07/2026.
Is ALEC a Buy or Sell From a Technical Analyst Perspective?
Based on today's Alector moving averages and other technical indicators, the daily buy/sell signal for ALEC stock is Strong Sell.
How Many Times Has Alector Stock Split?
Alector has split 0 times. (See the ALEC stock split history page for full effective split date and price information.)
How Many Employees Does Alector Have?
Alector has 103 employees, based on their latest Companies House report.
What is the current trading status of Alector (NASDAQ: ALEC)?
As of 20/05/2026, Alector (ALEC) is trading at a share price of 2.11 USD, with a previous close of 2.12 USD. The stock has fluctuated within a day range of 2.02 USD to 2.16 USD, while its 52-week range spans from 1.09 USD to 3.40 USD.
What Is Alector (ALEC) Price Target According to Analysts?
The average 12-month price target for Alector is 3.10 USD, with a high estimate of 6 USD and a low estimate of 1 USD. 3 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Neutral. The stock has an +46.92% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.